EGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancer. Article

Overview

authors

Giaccone, Giuseppe

publication date

June 1, 2005

published in

Nature clinical practice. Oncology Journal

Identity

PubMed ID

16264986

Additional Document Info

volume

2

issue

6